Literature DB >> 1431891

Distribution of free methylarginines in rat tissues and in the bovine brain.

S Ueno1, A Sano, K Kotani, K Kondoh, Y Kakimoto.   

Abstract

A sensitive and specific method for determining three forms of methylarginine, i.e., NG-monomethylarginine, NG,NG-dimethylarginine, and NG,N'G-dimethylarginine, in mammalian tissues was developed. After partial purification by ion-exchange chromatography, the methylarginines were derivatized to phenylthiocarbamyl compounds and quantitatively determined using HPLC with a reverse-phase C18 column. In rat organs, the highest concentrations of methylarginines were observed in the spleen. In rat brain, cerebellum and olfactory bulb contained large amounts of NG-monomethylarginine and NG,NG-dimethylarginine. A detailed study of the distribution of methylarginines in the bovine brain was also made, and the concentration of NG,N'G-dimethylarginine was almost the same in all regions. The cerebellar gray matter, hippocampus, and hypothalamus contained large amounts of methylarginines. The distribution of methylarginines seems to parallel the distribution of nitric oxide synthase, which is known to be inhibited by NG-monomethylarginine. This may indicate that methylarginines play some role in controlling nitric oxide synthase activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431891     DOI: 10.1111/j.1471-4159.1992.tb10088.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Basal and stimulated nitric oxide in control of kidney function in the aging rat.

Authors:  C Hill; A M Lateef; K Engels; L Samsell; C Baylis
Journal:  Am J Physiol       Date:  1997-06

Review 2.  Arginine, arginine analogs and nitric oxide production in chronic kidney disease.

Authors:  Chris Baylis
Journal:  Nat Clin Pract Nephrol       Date:  2006-04

3.  Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases.

Authors:  J M Leiper; J Santa Maria; A Chubb; R J MacAllister; I G Charles; G S Whitley; P Vallance
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

4.  Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase.

Authors:  R J MacAllister; H Parry; M Kimoto; T Ogawa; R J Russell; H Hodson; G S Whitley; P Vallance
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

5.  Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine.

Authors:  E Galea; S Regunathan; V Eliopoulos; D L Feinstein; D J Reis
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

Review 6.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

7.  Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.

Authors:  R J MacAllister; S A Fickling; G S Whitley; P Vallance
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Distribution of D-3-aminoisobutyrate-pyruvate aminotransferase in the rat brain.

Authors:  Masao Abe; Shinichiro Ochi; Yoko Mori; Kiyohiro Yamazaki; Takashi Ishimaru; Yuta Yoshino; Ryuji Fukuhara; Satoshi Tanimukai; Seiji Matsuda; Shu-Ichi Ueno
Journal:  BMC Neurosci       Date:  2014-04-27       Impact factor: 3.288

Review 9.  Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges.

Authors:  Jan Víteček; Antonín Lojek; Giuseppe Valacchi; Lukáš Kubala
Journal:  Mediators Inflamm       Date:  2012-09-04       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.